Novatox 100 Clostridium botulinum ATCC 3502 100 IU – KG Medics S.Korea

• Use of strains identified with Clostridium botulinum ATCC 3502

​

• Securing stable production

process technology by simplifying the undiluted solution manufacturing

process

​

• Production of more than 99% of undiluted solution

  
  

  Technology
  development
  capabilities

  • Expect safe product production/ management through bio factories equipped with state-of-the-art production facilities

  ​

  • Institute – 2,704 ,000 Vials can be produced annually with Botox Production Plant & Research